Bright Minds Biosciences (DRUG) News Today $24.82 +0.46 (+1.89%) Closing price 04:00 PM EasternExtended Trading$25.11 +0.29 (+1.17%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRUG Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Research Analysts Issue Forecasts for DRUG FY2025 EarningsJuly 6, 2025 | americanbankingnews.comAnalysts Offer Predictions for DRUG FY2025 EarningsJuly 4, 2025 | marketbeat.comBright Minds Biosciences (NASDAQ:DRUG) Earns Overweight Rating from Cantor FitzgeraldJuly 2, 2025 | marketbeat.comBright Minds Biosciences Inc. (NASDAQ:DRUG) Given Consensus Rating of "Buy" by AnalystsJune 26, 2025 | marketbeat.comDRUG FY2025 EPS Forecast Increased by Cantor FitzgeraldJune 11, 2025 | marketbeat.com40,379 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Purchased by Millennium Management LLCJune 4, 2025 | marketbeat.comBright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of "Buy" from AnalystsJune 1, 2025 | marketbeat.comBright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare ConferenceMay 28, 2025 | finance.yahoo.comWhat is Chardan Capital's Forecast for DRUG FY2025 Earnings?May 27, 2025 | marketbeat.comHC Wainwright Issues Pessimistic Outlook for DRUG EarningsMay 27, 2025 | marketbeat.comBright Minds Biosciences (NASDAQ:DRUG) Cut to "Sell" at Wall Street ZenMay 24, 2025 | marketbeat.comChardan Capital Reiterates Buy Rating for Bright Minds Biosciences (NASDAQ:DRUG)May 23, 2025 | marketbeat.comPoint72 Asset Management L.P. Buys Shares of 135,189 Bright Minds Biosciences Inc. (NASDAQ:DRUG)May 22, 2025 | marketbeat.comBright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025May 20, 2025 | globenewswire.comJanus Henderson Group PLC Buys New Position in Bright Minds Biosciences Inc. (NASDAQ:DRUG)May 18, 2025 | marketbeat.comBright Minds Biosciences (NASDAQ:DRUG) Upgraded to Strong-Buy at Cantor FitzgeraldMay 17, 2025 | marketbeat.comBright Minds Biosciences (DRUG) to Release Earnings on WednesdayMay 16, 2025 | marketbeat.comTD Cowen Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG)May 15, 2025 | marketbeat.comTD Cowen Initiates Coverage of Bright Minds Biosciences (DRUG) with Buy RecommendationMay 14, 2025 | msn.comBright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101May 13, 2025 | finance.yahoo.comChardan Capital Initiates a Buy Rating on Bright Minds Biosciences (DRUG)May 9, 2025 | theglobeandmail.comBright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Rating of "Buy" from BrokeragesMay 9, 2025 | marketbeat.comChardan Capital Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG)May 9, 2025 | marketbeat.comEpilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock UpsideMay 7, 2025 | benzinga.comChardan Capital Initiates Coverage of Bright Minds Biosciences (DRUG) with Buy RecommendationMay 7, 2025 | msn.comSchonfeld Strategic Advisors LLC Takes Position in Bright Minds Biosciences Inc. (NASDAQ:DRUG)May 7, 2025 | marketbeat.comAcuta Capital Partners LLC Takes Position in Bright Minds Biosciences Inc. (NASDAQ:DRUG)May 4, 2025 | marketbeat.com460,829 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Purchased by RA Capital Management L.P.May 3, 2025 | marketbeat.comAdvisorShares Investments LLC Sells 179,345 Shares of Bright Minds Biosciences Inc. (NASDAQ:DRUG)May 2, 2025 | marketbeat.com44,580 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Purchased by Boothbay Fund Management LLCMay 1, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Acquires New Position in Bright Minds Biosciences Inc. (NASDAQ:DRUG)May 1, 2025 | marketbeat.comBright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 StudyApril 28, 2025 | globenewswire.comVivo Capital LLC Invests $9.06 Million in Bright Minds Biosciences Inc. (NASDAQ:DRUG)April 23, 2025 | marketbeat.comWalleye Capital LLC Acquires New Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG)April 20, 2025 | marketbeat.comBright Minds Biosciences: A Buy With A Major Catalyst In Q2 2025April 17, 2025 | seekingalpha.comBright Minds Biosciences Inc. Common Stock (DRUG) After-HoursApril 14, 2025 | nasdaq.comSpringhill Fund Asset Management HK Co Ltd Purchases Shares of 60,648 Bright Minds Biosciences Inc. (NASDAQ:DRUG)April 8, 2025 | marketbeat.comAtika Capital Management LLC Takes Position in Bright Minds Biosciences Inc. (NASDAQ:DRUG)April 8, 2025 | marketbeat.comBright Minds Biosciences Inc. (NASDAQ:DRUG) Short Interest UpdateMarch 20, 2025 | marketbeat.comCantor Fitzgerald Has Weak Forecast for DRUG FY2025 EarningsMarch 17, 2025 | marketbeat.comBright Minds Biosciences (NASDAQ:DRUG) Trading Down 0.8% - Here's WhyMarch 15, 2025 | marketbeat.comBright Minds Biosciences expands Scientific Advisory BoardMarch 4, 2025 | markets.businessinsider.comBright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy ResearchMarch 4, 2025 | markets.businessinsider.comHC Wainwright Issues Pessimistic Estimate for DRUG EarningsFebruary 22, 2025 | marketbeat.comBright Minds Biosciences' (DRUG) "Buy" Rating Reiterated at HC WainwrightFebruary 20, 2025 | marketbeat.comBright Minds Biosciences (DRUG) Receives a New Rating from Piper SandlerFebruary 14, 2025 | markets.businessinsider.comBright Minds Biosciences (NASDAQ:DRUG) Announces Earnings Results, Beats Estimates By $0.24 EPSFebruary 14, 2025 | marketbeat.comBiotechs on the Brink: 2 Stocks With Huge Potential (DRUG)BriaCell Therapeutics and Recursion Pharmaceuticals are two biotech firms that may be poised for success in 2025; risk-tolerant investors might keep an eye out.February 14, 2025 | marketbeat.comBright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101January 26, 2025 | seekingalpha.comPiper Sandler Initiates Coverage of Bright Minds Biosciences (DRUG) with Overweight RecommendationJanuary 24, 2025 | msn.com Get Bright Minds Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter. Email Address DRUG Media Mentions By Week DRUG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRUG News Sentiment▼1.900.97▲Average Medical News Sentiment DRUG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRUG Articles This Week▼12▲DRUG Articles Average Week Get Bright Minds Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Avid Bioservices News Today uniQure News Today CorMedix News Today Cronos Group News Today GH Research News Today Syndax Pharmaceuticals News Today Immunome News Today Gyre Therapeutics News Today Vir Biotechnology News Today Ginkgo Bioworks News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRUG) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
